JP2024519845A5 - - Google Patents

Info

Publication number
JP2024519845A5
JP2024519845A5 JP2023571509A JP2023571509A JP2024519845A5 JP 2024519845 A5 JP2024519845 A5 JP 2024519845A5 JP 2023571509 A JP2023571509 A JP 2023571509A JP 2023571509 A JP2023571509 A JP 2023571509A JP 2024519845 A5 JP2024519845 A5 JP 2024519845A5
Authority
JP
Japan
Application number
JP2023571509A
Other languages
Japanese (ja)
Other versions
JPWO2022246459A5 (https=
JP2024519845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/072452 external-priority patent/WO2022246459A1/en
Publication of JP2024519845A publication Critical patent/JP2024519845A/ja
Publication of JPWO2022246459A5 publication Critical patent/JPWO2022246459A5/ja
Publication of JP2024519845A5 publication Critical patent/JP2024519845A5/ja
Pending legal-status Critical Current

Links

JP2023571509A 2021-05-19 2022-05-19 併用療法 Pending JP2024519845A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163190766P 2021-05-19 2021-05-19
US63/190,766 2021-05-19
PCT/US2022/072452 WO2022246459A1 (en) 2021-05-19 2022-05-19 Combination therapy

Publications (3)

Publication Number Publication Date
JP2024519845A JP2024519845A (ja) 2024-05-21
JPWO2022246459A5 JPWO2022246459A5 (https=) 2025-05-27
JP2024519845A5 true JP2024519845A5 (https=) 2025-05-27

Family

ID=82492721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571509A Pending JP2024519845A (ja) 2021-05-19 2022-05-19 併用療法

Country Status (7)

Country Link
US (1) US20240148733A1 (https=)
EP (1) EP4340883A1 (https=)
JP (1) JP2024519845A (https=)
CN (1) CN117337193A (https=)
AR (1) AR125921A1 (https=)
TW (1) TW202313048A (https=)
WO (1) WO2022246459A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3224341A1 (en) * 2021-09-01 2023-03-09 Novartis Ag Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers
AU2023349151A1 (en) 2022-09-29 2025-04-03 Insilico Medicine Ip Limited Tead inhibitors and methods of uses thereof
WO2024176131A1 (en) * 2023-02-23 2024-08-29 Novartis Ag Tead- and kras g12d-inhibitor combinations for treating cancer
EP4688730A1 (en) * 2023-03-27 2026-02-11 Vivace Therapeutics, Inc. Synthesis of a hippo-yap pathway modulator and a polymorph thereof
WO2025054190A1 (en) * 2023-09-05 2025-03-13 Vivace Therapeutics, Inc. Pharmaceutical formulations and dosing schedules of a yap/taz-tead inhibitor
WO2025101655A1 (en) * 2023-11-08 2025-05-15 Vivace Therapeutics, Inc. Compounds for modulating yap-tead/hippo pathway
WO2025122956A1 (en) * 2023-12-08 2025-06-12 Vivace Therapeutics, Inc. Combination therapy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201992781A1 (ru) * 2017-05-22 2020-04-01 Эмджен Инк. Ингибиторы g12c kras и способы их применения
CA3073543A1 (en) * 2017-08-21 2019-02-28 Vivace Therapeutics, Inc. Benzosulfonyl compounds
HRP20230377T1 (hr) * 2017-11-15 2023-06-23 Mirati Therapeutics, Inc. Inhibitori mutacije kras g12c
PT3735299T (pt) * 2018-11-09 2024-11-25 Hoffmann La Roche Compostos de anéis fundidos
CA3118752A1 (en) * 2018-11-09 2020-05-14 Vivace Therapeutics, Inc. Bicyclic compounds
JP7377679B2 (ja) * 2018-11-19 2023-11-10 アムジエン・インコーポレーテツド がん治療のためのkrasg12c阻害剤及び1種以上の薬学的に活性な追加の薬剤を含む併用療法
HUE070525T2 (hu) * 2019-04-16 2025-06-28 Vivace Therapeutics Inc Biciklusos vegyületek
CN114728905B (zh) * 2019-11-13 2025-08-01 基因泰克公司 治疗性化合物及使用方法
TW202128699A (zh) * 2019-11-27 2021-08-01 美商建南德克公司 治療性化合物
WO2021120890A1 (en) * 2019-12-20 2021-06-24 Novartis Ag Pyrazolyl derivatives useful as anti-cancer agents
EP4114830A1 (en) * 2020-03-04 2023-01-11 Genentech, Inc. Heterobifunctional molecules as tead inhibitors
AU2021268094A1 (en) * 2020-05-08 2022-10-27 Cancer Research Technology Ltd. Tricyclic heterocycles useful as TEAD binders
US11787775B2 (en) * 2020-07-24 2023-10-17 Genentech, Inc. Therapeutic compounds and methods of use

Similar Documents

Publication Publication Date Title
JP2024532374A5 (https=)
JP2024519845A5 (https=)
JP2025511161A5 (https=)
CL2026000414A1 (es) Dispositivo de perforación y procesamiento de fluidos
CL2026000158A1 (es) Planta ptx dinámica
BR102023005164A2 (https=)
BY13169U (https=)
BY13166U (https=)
CN307048984S (https=)
CN307048551S (https=)
CN307048487S (https=)
CN307047789S (https=)
CN307047724S (https=)
CN307046101S (https=)
CN307045588S (https=)
CN307045256S (https=)
CN307044833S (https=)
CN307044518S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13142U (https=)